Crystal Mackall
Net worth: 7 M $ as of 2024-04-29
Profile
Crystal Mackall is the founder of Lyell Immunopharma, Inc. (founded in 2018) and Cargo Therapeutics, Inc. (founded in 2019).
She held the title of Director at Cargo Therapeutics, Inc. from 2021 to 2023.
Dr. Mackall is also the founder of Link Cell Therapies, Inc. Dr. Mackall's current jobs include being a Director at UCSF Stanford Health Care, The Parker Institute For Cancer Immunotherapy, and a Member of the American Society of Clinical Investigation.
Dr. Mackall completed her undergraduate degree at the University of Akron and obtained a doctorate from Northeast Ohio Medical University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
0.96% | 2023-11-09 | 378,424 ( 0.96% ) | 7 M $ | 2024-04-29 |
Crystal Mackall active positions
| Companies | Position | Start |
|---|---|---|
UCSF Stanford Health Care
 UCSF Stanford Health Care Miscellaneous Commercial ServicesCommercial Services UCSF Stanford Health Care is a healthcare organization that integrates a top-tier medical school with exceptional hospitals to advance human health. The American company provides resources for finding people and locations at Stanford Medicine. | Director/Board Member | - |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Director/Board Member | - |
| American Society of Clinical Investigation | Corporate Officer/Principal | - |
Former positions of Crystal Mackall
| Companies | Position | End |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Founder | 2023-09-30 |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
| LYELL IMMUNOPHARMA, INC. | Founder | - |
Training of Crystal Mackall
| University of Akron | Undergraduate Degree |
| Northeast Ohio Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
UCSF Stanford Health Care
UCSF Stanford Health Care Miscellaneous Commercial ServicesCommercial Services UCSF Stanford Health Care is a healthcare organization that integrates a top-tier medical school with exceptional hospitals to advance human health. The American company provides resources for finding people and locations at Stanford Medicine. | Commercial Services |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
| American Society of Clinical Investigation |
- Stock Market
- Insiders
- Crystal Mackall
